Annual Drug Patent Expiration for KOSELUGO

New patent for the drug Astrazeneca KOSELUGO – DrugPatentWatch

Less than a minute

[ad_1]

Annual Drug Patent Expiration for KOSELUGO

Koselugo is a drug marketed by Astrazeneca and included in one NDA. It is available from a single supplier. There are four patents protecting this drug.

This drug has one hundred and forty-two patent family members in thirty-nine countries.

The generic ingredient in KOSELUGO is selumetinib sulfate. One registered supplier for this compound. Additional details are available on the selumetinib sulfate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com